Sign in to view content

Impact of Posterior Vitreous Detachment at Baseline on Treatment Outcomes For Diabetic Macular Edema in the VISTA and VIVID Trials

Ferhina S Ali, MD, MPH

Video
Published 2017

Related

Efficacy, Durability, and Safety of Faricimab in DME: 2-Year Results From the Phase 3 YOSEMITE and RHINE Trials
Jennifer I. Lim, MD, FARVO, FASRS
Updates from the Field
2022
Vitreoretinal Interface Disorders From the Perspective of Retinal Surgeons
Aniruddha Dinkar Mahindrakar, MS Ophthalmology
On Demand Cases, Courses, and Papers
2019
Efficacy, Safety, and Durability of Faricimab in Diabetic Macular Edema (DME): One-Year Results From the Phase 3 YOSEMITE and RHINE Trials
Caroline Baumal, MD, FASRS
Annual Meeting Talks
2021

Category: Diabetic Retinopathy

See more